Cresco Labs stock analysis
Want to see TSE:CL full AI Analyst Report?
Cresco Labs (CL) Stock Price & Analysis
CL Stock Chart & Stats
- Day’s Range
- CAD 0.68 - CAD 0.68
- 52-Week Range
- CAD 0.66 - CAD 3.12
- Previous Close
- CAD 0.71
- Volume
- N/A
- Average Volume (3M)
- 77.97K
- Market Cap
- CAD 314.15M
- Enterprise Value
- CAD 991.26M
- Total Cash (Recent Filing)
- CAD 41.17M
- Total Debt (Recent Filing)
- CAD 624.01M
- Price to Earnings (P/E)
- ―
- Beta
- 2.32
- Next Earnings
- Mar 17, 2027 (Est.)
- EPS Estimate
- -0.03
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Retail And Branded Market Leadership
Strong store productivity and leading branded share indicate meaningful customer demand and operating advantages across major regulated markets. These positions can support shelf access, repeat purchases, and better utilization of the company’s retail and wholesale infrastructure over the next several quarters.
Positive Cash Generation
Positive operating and free cash flow gives Cresco internally generated funding for operations, store investments, and product development without relying entirely on external capital. The accompanying EBITDA margin and cash conversion suggest improving operating discipline, even though consistency still needs to be demonstrated.
Operational Productivity And Cultivation Improvements
Higher cultivation yields and efficiency initiatives can improve unit economics by increasing sellable output and spreading fixed costs across more revenue. Continued automation and facility improvements therefore provide a durable path to stronger margins and cash generation as upgraded capacity is utilized.
Bears Say
Elevated Leverage And Reduced Equity Cushion
Debt materially exceeds the equity base, leaving Cresco more exposed to earnings volatility and refinancing conditions. The shrinking equity cushion reduces financial flexibility and may constrain the company’s ability to fund expansion, absorb operating setbacks, or allocate capital toward higher-return opportunities.
Persistent Net Losses
Operating improvements have not yet translated into consistent bottom-line profitability, so the business remains dependent on continued execution to build shareholder value. Persistent losses can limit reinvestment capacity and make the benefits of revenue growth less durable until interest and other costs are covered.
Competitive Pricing And Margin Pressure
Consumers and operators are shifting toward larger value formats while promotional activity remains elevated, forcing Cresco to balance competitiveness against margin protection. This pressure can weaken wholesale economics and delay margin expansion, particularly while higher-cost inventory continues moving through the business.
CL FAQ
What was Cresco Labs’s price range in the past 12 months?
What is Cresco Labs’s market cap?
When is Cresco Labs’s upcoming earnings report date?
How were Cresco Labs’s earnings last quarter?
Is Cresco Labs overvalued?
Does Cresco Labs pay dividends?
What is Cresco Labs’s EPS estimate?
How many shares outstanding does Cresco Labs have?
What happened to Cresco Labs’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Cresco Labs?
What is the TipRanks Smart Score and how is it calculated?
Cresco Labs Stock Smart Score
Company Description
Cresco Labs
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Charles Bachtell
- Employees
- 2,900
- Website
- www.crescolabs.com
- Address
- 600 W. Fulton Street, Chicago, IL, 60661, US
Cresco Labs (CL) Earnings & Revenues
CL Company Deck
CL Earnings Call
Earnings Call SentimentPositive
The call was broadly positive: Cresco delivered its planned Q3 results, grew revenue, generated $21 million of free cash flow, expanded its Pennsylvania and Ohio retail footprints, launched new products and reported strong market share and productivity positions. Near-term challenges include 47% gross margin affected by higher-cost inventory, expected low-single-digit sequential revenue decline in Q4, pricing and promotional pressure, a measured Kentucky ramp and uncertainty around hemp, Texas and Pennsylvania regulatory developments.
View all TSE:CL earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |












